MAP Kinase Kinase 1, antagonists & inhibitors
- Name
- MAP Kinase Kinase 1, antagonists & inhibitors
- Accession Number
- DBCAT001678
- Description
Not Available
- Drugs
Drug Drug Description Cobimetinib An antineoplastic agent and selective inhibitor of the mitogen-activated extracellular kinase (MEK) pathway used to treat unresectable or metastatic melanoma. Trametinib A kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer. Binimetinib A medication used to treat metastatic melanoma with specific mutations. - Drugs & Drug Targets